Viewing Study NCT01580293


Ignite Creation Date: 2025-12-25 @ 1:18 AM
Ignite Modification Date: 2026-05-17 @ 5:47 AM
Study NCT ID: NCT01580293
Status: COMPLETED
Last Update Posted: 2023-11-07
First Post: 2012-03-28
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hemophilia A View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hemophilia A, factor VIII, prophylaxis View